https://routeofadministration.com 2026-11-01T13:10:47.952Z daily 1 https://routeofadministration.com/sections/nanoparticle-carriers 2026-10-30T11:35:58.092Z weekly 0.5 https://routeofadministration.com/sections/pharmacokinetics 2026-10-15T11:31:39.739Z weekly 0.5 https://routeofadministration.com/sections/bbb-and-cns-access 2026-10-08T11:10:28.423Z weekly 0.5 https://routeofadministration.com/sections/peptide-stability 2026-09-26T04:11:17.043Z weekly 0.5 https://routeofadministration.com/sections/glp-1-tolerability-and-adherence 2026-11-01T13:10:47.952Z weekly 0.5 https://routeofadministration.com/sections/features 2026-09-17T00:46:27.708Z weekly 0.5 https://routeofadministration.com/authors/tobias-mehring 2026-11-01T13:10:47.952Z weekly 0.4 https://routeofadministration.com/authors/marcus-tully-byrne 2026-11-01T13:10:47.952Z weekly 0.4 https://routeofadministration.com/authors/s-verine-okafor 2026-11-01T13:10:47.952Z weekly 0.4 https://routeofadministration.com/authors/priya-venkatesan 2026-11-01T13:10:47.952Z weekly 0.4 https://routeofadministration.com/posts/companies-developing-non-injectable-glp-1-formulations-for-tolerability https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/a31584ce-9173-4283-820c-0b3edb2ab1bb.jpeg 2026-11-01T13:10:47.952Z monthly 0.7 https://routeofadministration.com/posts/the-pharmacokinetic-case-against-weekly-bolus-dosing-in-glp-1-tolerability https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/faebecab-1da1-4647-a947-82dce09806e9.jpeg 2026-10-31T12:40:41.784Z monthly 0.7 https://routeofadministration.com/posts/olfactory-and-trigeminal-pathways-that-carry-lipid-nanoparticles-from-nasal-epit https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/f3e2751c-4bbe-498b-8979-bc1bfb7134ff.png 2026-10-30T11:35:58.092Z monthly 0.7 https://routeofadministration.com/posts/how-columbia-university-built-a-30-year-nanoparticle-patent-estate-that-defines https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/dd5bbd9e-e9c4-4549-9e05-2fda8b5631f8.jpeg 2026-10-29T12:56:23.532Z monthly 0.7 https://routeofadministration.com/posts/why-large-molecule-peptides-require-nanoparticle-encapsulation-to-survive-the-na https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/282421be-387c-4984-8a64-9e16797508e0.jpeg 2026-10-27T11:31:36.094Z monthly 0.7 https://routeofadministration.com/posts/proprietary-nanoparticle-ip-estates-that-enable-nose-to-brain-peptide-delivery-a https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/56ad340a-a3cb-43ca-b397-e58a65758b24.jpeg 2026-10-26T10:56:01.589Z monthly 0.7 https://routeofadministration.com/posts/nanoparticle-platforms-in-clinical-and-preclinical-development-for-intranasal-cn https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/acd1d1d5-279a-4561-85db-0dbeecb4a969.jpeg 2026-10-25T12:16:00.405Z monthly 0.7 https://routeofadministration.com/posts/university-spinouts-with-foundational-patent-estates-in-nanoparticle-peptide-del https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/35028b48-ed47-4e03-9c4c-877dde79b5e7.jpeg 2026-10-24T12:40:32.027Z monthly 0.7 https://routeofadministration.com/posts/nanoparticle-size-and-zeta-potential-effects-on-in-vivo-behavior https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/5cdf46c7-63ea-4c4d-8d0b-75b42c399d6e.jpeg 2026-10-23T11:55:44.565Z monthly 0.7 https://routeofadministration.com/posts/nanoparticle-scale-up-from-lab-bench-to-gmp-manufacturing https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/c500cd16-4ff2-4a9f-86a3-1bbded3846a1.jpeg 2026-10-22T11:31:29.731Z monthly 0.7 https://routeofadministration.com/posts/exosome-and-extracellular-vesicle-platforms-for-cns-peptide-delivery https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/203dd260-1497-4822-821c-0a7f2cac5bf4.jpeg 2026-10-19T11:31:18.641Z monthly 0.7 https://routeofadministration.com/posts/regulatory-classification-of-nanoparticle-drug-products-at-the-fda https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/54f87cba-ed82-4bc0-9952-6f60fed3a2e1.jpeg 2026-10-18T11:30:39.221Z monthly 0.7 https://routeofadministration.com/posts/nanoparticle-surface-functionalization-for-blood-brain-barrier-crossing https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/c5aa77ab-66f3-41f4-b145-bad1aaf80d8c.jpeg 2026-10-17T12:20:41.816Z monthly 0.7 https://routeofadministration.com/posts/lipid-nanoparticle-formulation-variables-and-peptide-encapsulation-efficiency https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/78ed6393-5358-4a99-9911-d5749b320b79.jpeg 2026-10-16T12:36:41.762Z monthly 0.7 https://routeofadministration.com/posts/half-life-extension-strategies-for-peptide-therapeutics https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/d9049752-3da0-4adf-a020-466e22e0535d.jpeg 2026-10-15T11:31:39.739Z monthly 0.7 https://routeofadministration.com/posts/nasal-absorption-variability-and-its-impact-on-dose-reproducibility https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/61d74493-4fa1-4090-b7e1-f48eef5e137e.jpeg 2026-10-14T11:31:29.473Z monthly 0.7 https://routeofadministration.com/posts/pk-pd-modeling-for-novel-delivery-route-development https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/190be2ca-d9cb-4b07-b989-8bb49b1da26b.jpeg 2026-10-13T11:36:36.545Z monthly 0.7 https://routeofadministration.com/posts/first-pass-metabolism-avoidance-by-route-of-administration https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/63ccde27-6884-4ca2-af50-c54bc63feb21.jpeg 2026-10-11T11:55:35.622Z monthly 0.7 https://routeofadministration.com/posts/csf-pharmacokinetics-and-brain-parenchyma-drug-distribution https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/9bbb1e10-d50f-40b3-a44a-b94bec531704.jpeg 2026-10-08T11:10:28.423Z monthly 0.7 https://routeofadministration.com/posts/focused-ultrasound-for-transient-blood-brain-barrier-opening https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/e0bbf905-3019-46d6-a866-d5efde2c3c21.jpeg 2026-10-07T11:30:34.099Z monthly 0.7 https://routeofadministration.com/posts/biotech-companies-developing-nose-to-brain-nanoparticle-platforms-for-cns-indica https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/a52ef1f0-83d4-4920-8c1e-12d1fdb67159.png 2026-10-06T11:30:47.794Z monthly 0.7 https://routeofadministration.com/posts/glp-1-receptor-agonists-and-neurodegeneration-research https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/5371f2d2-2a06-4e73-a2f2-5c74927a361b.jpeg 2026-10-05T12:25:56.199Z monthly 0.7 https://routeofadministration.com/posts/intranasal-glp-1-delivery-for-addiction-and-reward-circuit-modulation https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/da2596ed-3ec0-4c34-a7da-2ee711d12ec9.jpeg 2026-10-03T12:10:07.995Z monthly 0.7 https://routeofadministration.com/posts/receptor-mediated-transcytosis-across-the-blood-brain-barrier https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/451a7edf-4d7b-4219-abd1-7f31a21e3eff.jpeg 2026-10-02T13:00:45.212Z monthly 0.7 https://routeofadministration.com/posts/glp-1-receptor-distribution-in-the-human-brain https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/6601f980-278a-4425-a70d-47f3acc619d7.jpeg 2026-10-01T11:45:11.156Z monthly 0.7 https://routeofadministration.com/posts/cmax-and-tmax-profiles-across-subcutaneous-intravenous-and-intranasal-routes https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/39ee1cbe-85d5-49b8-bad9-d726cf028a50.jpeg 2026-09-30T16:40:48.143Z monthly 0.7 https://routeofadministration.com/posts/volume-of-distribution-and-cns-penetration-for-therapeutic-peptides https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/4920fa54-8741-4189-9b05-3d3882a23dea.jpeg 2026-09-30T02:06:01.670Z monthly 0.7 https://routeofadministration.com/posts/absolute-bioavailability-of-intranasal-peptide-formulations https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/82efca6b-1e6c-4e2d-abb3-abd9eccb03a8.jpeg 2026-09-28T06:09:58.349Z monthly 0.7 https://routeofadministration.com/posts/glp-1-pharmacokinetics-and-half-life-engineering-in-approved-analogs https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/e5c968b5-5d4b-47ee-88b9-d69a4017ca6c.jpeg 2026-09-26T22:54:38.930Z monthly 0.7 https://routeofadministration.com/posts/higher-order-structure-characterization-of-therapeutic-peptides https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/0ad0b204-48f0-4ef7-9be5-976aafd7a8b8.jpeg 2026-09-26T04:11:17.043Z monthly 0.7 https://routeofadministration.com/posts/accelerated-stability-testing-protocols-for-peptide-drug-products https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/a845ebda-cc4d-4fa8-97c4-7e67b28f3e80.jpeg 2026-09-22T11:33:54.626Z monthly 0.7 https://routeofadministration.com/posts/proteolytic-barriers-at-the-nasal-mucosa-for-peptide-therapeutics https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/a8e31a7e-651a-46da-92b6-9dcbb9bfad1a.jpeg 2026-09-21T13:05:56.601Z monthly 0.7 https://routeofadministration.com/posts/nanoparticle-encapsulation-as-a-peptide-stability-strategy https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/d2bff4d9-0919-4b7f-b1ce-7c023e143f0e.jpeg 2026-09-20T11:33:44.910Z monthly 0.7 https://routeofadministration.com/posts/nose-to-brain-transport-mechanisms-for-peptide-therapeutics https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/089ad4c8-8a9d-449f-ba3e-a2c8c9de7604/generated/c0eadad0-0c66-48b9-97bf-b42aa4b72349.jpeg 2026-09-17T00:46:27.708Z monthly 0.7